Ginkgo Bioworks (DNA) News Today $6.59 -0.06 (-0.84%) Closing price 03/27/2025 03:59 PM EasternExtended Trading$6.59 0.00 (-0.06%) As of 03/27/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period BTIG Reaffirms Their Sell Rating on Ginkgo Bioworks Holdings (DNA)March 18, 2025 | markets.businessinsider.comErste Asset Management GmbH Raises Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Erste Asset Management GmbH boosted its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 47.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 739,332 shares of the company'sMarch 15, 2025 | marketbeat.comSPX Gestao de Recursos Ltda Makes New $491,000 Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)SPX Gestao de Recursos Ltda acquired a new position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 50,000 shMarch 11, 2025 | marketbeat.comGinkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Acquired by Prescott Group Capital Management L.L.C.Prescott Group Capital Management L.L.C. boosted its stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 33.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 361,750 shares of the company's stockMarch 8, 2025 | marketbeat.comVW's cheapest EV will have Rivian DNA and who is bidding for Canoo's assetsMarch 6, 2025 | techcrunch.comGinkgo Bioworks (NYSE:DNA) Shares Up 6.6% - What's Next?Ginkgo Bioworks (NYSE:DNA) Trading 6.6% Higher - Should You Buy?March 3, 2025 | marketbeat.comGinkgo Bioworks price target lowered to $12 from $16 at TD CowenFebruary 28, 2025 | markets.businessinsider.comGinkgo Bioworks (NYSE:DNA) Shares Gap Down - Should You Sell?Ginkgo Bioworks (NYSE:DNA) Shares Gap Down - Time to Sell?February 27, 2025 | marketbeat.com2025 Is Make Or Break For Ginkgo BioworksFebruary 27, 2025 | seekingalpha.comGinkgo Bioworks (DNA) to Release Quarterly Earnings on ThursdayGinkgo Bioworks (NYSE:DNA) will be releasing earnings after the market closes on Thursday, March 6. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=443042)February 27, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Posts Earnings Results, Misses Expectations By $0.37 EPSGinkgo Bioworks (NYSE:DNA - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($1.82) earnings per share for the quarter, missing the consensus estimate of ($1.45) by ($0.37). Ginkgo Bioworks had a negative return on equity of 58.54% and a negative net margin of 298.78%.February 26, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Releases Earnings Results, Misses Estimates By $0.37 EPSGinkgo Bioworks (NYSE:DNA - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($1.82) EPS for the quarter, missing the consensus estimate of ($1.45) by ($0.37). Ginkgo Bioworks had a negative return on equity of 58.54% and a negative net margin of 298.78%.February 26, 2025 | marketbeat.comGinkgo Bioworks falls -12.5%February 26, 2025 | markets.businessinsider.comGinkgo subleases part of HQ, looks to address $65M of excess spaceFebruary 26, 2025 | bizjournals.comGinkgo Bioworks options imply 17.6% move in share price post-earningsFebruary 26, 2025 | markets.businessinsider.comWilliam Blair Sticks to Its Sell Rating for Ginkgo Bioworks Holdings (DNA)February 26, 2025 | markets.businessinsider.comFlywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionFebruary 26, 2025 | benzinga.comGinkgo Bioworks Holdings, Inc. (DNA) Q4 2024 Earnings Call TranscriptFebruary 25, 2025 | seekingalpha.comGinkgo Bioworks Holdings, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 25, 2025 | seekingalpha.comGinkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 25, 2025 | prnewswire.comGinkgo Bioworks (NYSE:DNA) Stock Price Down 9.3% - Should You Sell?Ginkgo Bioworks (NYSE:DNA) Stock Price Down 9.3% - Here's What HappenedFebruary 24, 2025 | marketbeat.comGinkgo Bioworks (DNA) Expected to Announce Earnings on TuesdayGinkgo Bioworks (NYSE:DNA) will be releasing earnings after the market closes on Tuesday, February 25, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=443042)February 23, 2025 | marketbeat.comGinkgo Bioworks integrates Callisto for NGS processesFebruary 22, 2025 | markets.businessinsider.comGinkgo Bioworks (NYSE:DNA) Trading Down 6.3% - Here's What HappenedGinkgo Bioworks (NYSE:DNA) Trading Down 6.3% - Time to Sell?February 21, 2025 | marketbeat.comGinkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput labFebruary 21, 2025 | prnewswire.comGinkgo Bioworks partners with HaDEA in up to EUR 24M projectFebruary 21, 2025 | markets.businessinsider.comGinkgo Bioworks (DNA) to Release Earnings on TuesdayGinkgo Bioworks (NYSE:DNA) will be releasing earnings after the market closes on Tuesday, February 25, Financial Modeling Prep reports.February 21, 2025 | marketbeat.comGinkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of CareFebruary 20, 2025 | prnewswire.comGinkgo Bioworks (NYSE:DNA) Shares Down 6.3% - Time to Sell?Ginkgo Bioworks (NYSE:DNA) Stock Price Down 6.3% - Should You Sell?February 19, 2025 | marketbeat.comGinkgo Bioworks Holdings, Inc. (NYSE:DNA) Short Interest Up 5.4% in JanuaryGinkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) saw a significant increase in short interest in January. As of January 31st, there was short interest totalling 8,250,000 shares, an increase of 5.4% from the January 15th total of 7,830,000 shares. Based on an average trading volume of 1,490,000 shares, the days-to-cover ratio is currently 5.5 days. Currently, 22.6% of the company's shares are short sold.February 18, 2025 | marketbeat.comGinkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results PresentationFebruary 18, 2025 | prnewswire.comGinkgo Bioworks (NYSE:DNA) Trading 8.8% Higher - Here's WhyGinkgo Bioworks (NYSE:DNA) Trading Up 8.8% - Time to Buy?February 15, 2025 | marketbeat.comDNA from Fiserv Selected by Third Federal as Part of its Digital TransformationFebruary 14, 2025 | businesswire.comGinkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should KnowFebruary 13, 2025 | msn.comGinkgo Bioworks (NYSE:DNA) Trading Down 5.4% - What's Next?Ginkgo Bioworks (NYSE:DNA) Stock Price Down 5.4% - Here's WhyFebruary 12, 2025 | marketbeat.comSG Americas Securities LLC Takes $199,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)SG Americas Securities LLC acquired a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 20,295 shares of the company's stock, valued at approxFebruary 9, 2025 | marketbeat.comForbes J M & Co. LLP Has $6.89 Million Stock Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Forbes J M & Co. LLP increased its position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 461.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 701,732 shares of the company's stock after aFebruary 8, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Stock Price Up 7.9% - What's Next?Ginkgo Bioworks (NYSE:DNA) Shares Up 7.9% - Time to Buy?February 7, 2025 | marketbeat.comGinkgo Bioworks CFO Dmytruk sells $9,947 in stockFebruary 6, 2025 | msn.comGinkgo Bioworks' chief accounting officer sells $4,933 in stockFebruary 6, 2025 | msn.comGinkgo Bioworks (NYSE:DNA) Stock Price Down 6.8% - What's Next?Ginkgo Bioworks (NYSE:DNA) Shares Down 6.8% - Here's What HappenedFebruary 6, 2025 | marketbeat.comGinkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference SeriesFebruary 6, 2025 | prnewswire.comGinkgo Bioworks (NYSE:DNA) Stock Price Up 7.9% - Here's WhyGinkgo Bioworks (NYSE:DNA) Shares Up 7.9% - Time to Buy?February 5, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Shares Gap Down - Time to Sell?Ginkgo Bioworks (NYSE:DNA) Shares Gap Down - Here's WhyFebruary 3, 2025 | marketbeat.comGinkgo Bioworks Holdings, Inc. (NYSE:DNA) Position Trimmed by JPMorgan Chase & Co.JPMorgan Chase & Co. lowered its stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 97.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,305 shares of the company's stock after selling 576,747 shares during thFebruary 3, 2025 | marketbeat.comPFG Investments LLC Lowers Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)PFG Investments LLC cut its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 90.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 18,900 shares of the company's stock after selling 170February 2, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Trading Down 6.3% - Time to Sell?Ginkgo Bioworks (NYSE:DNA) Trading Down 6.3% - Here's What HappenedJanuary 31, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Trading 9.7% Higher - What's Next?Ginkgo Bioworks (NYSE:DNA) Shares Up 9.7% - Time to Buy?January 30, 2025 | marketbeat.comGinkgo Bioworks Holdings, Inc. (DNA) Stock Moves -0.24%: What You Should KnowJanuary 30, 2025 | msn.comGinkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris' PathJanuary 30, 2025 | seekingalpha.com Remove Ads Get Ginkgo Bioworks News Delivered to You Automatically Sign up to receive the latest news and ratings for DNA and its competitors with MarketBeat's FREE daily newsletter. Email Address DNA Media Mentions By Week DNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DNA News Sentiment▼0.520.78▲Average Medical News Sentiment DNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DNA Articles This Week▼06▲DNA Articles Average Week Remove Ads Get Ginkgo Bioworks News Delivered to You Automatically Sign up to receive the latest news and ratings for DNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vera Therapeutics News Today Galapagos News Today Kiniksa Pharmaceuticals News Today Schrödinger News Today IDEAYA Biosciences News Today Ascentage Pharma Group International News Today Wave Life Sciences News Today Immunocore News Today ANI Pharmaceuticals News Today Dyne Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:DNA) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ginkgo Bioworks Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ginkgo Bioworks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
